Companies » Company Overview » Glaxosmithkline Pharma Ltd.
 
 

Glaxosmithkline Pharma Ltd.

  • BSE: 500660
  • Sector: Health care
  • NSE: GLAXO
  • ISIN Code: INE159A01016
  • BSE

    LIVE

    14:51 | 06 Jul

  • 3343.30
  • 1.50
    (0.04%)
  • Open
    3349.00
  • HIGH
    3350.00
  • LOW
    3316.00
  • NSE

    LIVE

    14:51 | 06 Jul

  • 3353.70
  • 6.30
    (0.19%)
  • Open
    3300.00
  • HIGH
    3354.10
  • LOW
    3300.00
 
bse
14:51 PM,6th Jul 2015
3343.30
1.50 (0.04%)
Previous Close 3341.80
Volume 1830
52-Week high 3550.00
52-Week low 2400.00
P/E 69.52
Mkt Cap.(Rs cr) 28318
Bid Price 3345.05
Bid Quantity 3.00
Offer Price 3349.95
Offer Quantity 10.00
NSE
14:51 PM,6th Jul 2015

3353.70
6.30 (0.19%)
Bse
14:51 PM,6th Jul 2015

3343.30
1.50 (0.04%)
nse
14:51 PM,6th Jul 2015
3353.70
6.30 (0.19%)
Previous Close 3347.40
Volume 5582
52-Week high 3550.00
52-Week low 2440.50
P/E 69.52
Mkt Cap.(Rs cr) 28318
Bid Price 3350.10
Bid Quantity 8.00
Offer Price 3353.60
Offer Quantity 5.00

Glaxosmithkline Pharma Ltd. (GLAXO) - Company Information

GlaxoSmithKline Pharma Ltd is one of the world's leading research-based pharmaceutical and healthcare companies. The company's product portfolio includes prescription medicines and vaccines. Their prescription medicines range across therapeutic areas, such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases. They also offer a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, c... [More]

Key Fundamentals
Market Cap (Rs cr) 28,318
EPS - TTM (Rs)

[*C]

48.09
P/E Ratio (x)

[*C]

69.52
Face Value (Rs) 10
Latest Dividend (%) 625.00
Latest Dividend Date 23 Jul 2015
Dividend Yield (%) 1.87
Book Value / Share (Rs)

[*C]

215.94
P/B Ratio (x)

[*C]

15.48
[*C] Consolidated [*S] Standalone
STOCK STRENGTH
Today's Low/High
3316.00
3350.00
Week Low/High
3210.00
3399.00
Month Low/High
3124.00
3399.00
YEAR Low/High
2400.00
3550.00
All TIME Low/High
25.75
3550.00
Peer Group
Company Last Change(%)
Aurobindo Pharma 1448.50 2.08
Cadila Health. 1832.90 -0.25
Glenmark Pharma. 1020.20 0.11
Glaxosmit Pharma 3343.30 0.04
Divi's Lab. 1906.00 2.37
Torrent Pharma. 1324.15 0.14
Piramal Enterp. 960.00 -0.54
Returns
Period Glaxosmit Pharma Sensex NIFTY
1 Week 1.88% 1.76% 2.20%
1 Month 4.71% 5.09% 4.77%
3 Month -0.26% -1.31% -1.83%
6 Month 6.08% 4.24% 4.61%
1 Year 31.21% 8.36% 9.68%
3 Year 65.35% 60.56% 59.90%
Period Glaxosmit Pharma Sensex NIFTY
1 Week 2.03% 1.76% 2.20%
1 Month 4.83% 5.09% 4.77%
3 Month -0.19% -1.31% -1.83%
6 Month 6.43% 4.24% 4.61%
1 Year 31.56% 8.36% 9.68%
3 Year 66.32% 60.56% 59.90%
SHAREHOLDER VOTING RECOMMENDATION
Date Advisory Report
24/02 IIAS PDF Icon
Financial Results
Particulars (Rs cr) Mar 2015 Mar 2014 %Chg
Net Sales 620.31 609.85 1.72
Other Income 40.48 44.88 -9.8
Total Income 660.79 654.73 0.93
Total Expenses 500.35 502.25 -0.38
Operating Profit 160.44 152.48 5.22
Net Profit 102.85 96.54 6.54
Equity Capital 84.7 84.7 -
SHAREHOLDING PATTERN
As on Mar 2015
Research Reports
Date Broker Action Price Report
13/08 Angel Broking Neutral 2513 PDF Icon
28/04 Angel Broking Neutral 2450 PDF Icon
21/04 Centrum Sell 2492 PDF Icon
13/11 Centrum Sell 2470 PDF Icon
Company information
Chairman : D S Parekh
Vice Chairman : V Thyagarajan
Managing Director : H B Joshipura
Director : R R Bajaaj
Director : N Kaviratne
Director : P V Nayak
Executive Director (HR) : R C Sequeira
Director : D Sundaram
Company Secretary : A A Nadkarni
Director : P V Bhide
Executive Director (Technical) : Raju Krishnaswamy
Director : A N Roy
Non-Exec. & Independent Dir. : Anjali P Bansal
Non Executive Director : Regis Simard
AUDITOR: Price Waterhouse & Co
IND NAME: Pharmaceuticals - Multinational
HOUSE NAME: MNC Associate - Glaxo
Registered office
GSK House, Dr Annie Besant Road Worli,
Mumbai,Maharashtra-400030
Ph: 91-022-24959595
E-mail: ajay.a.nadkarni@gsk.com
URL: http://www.gsk-india.com

Quick Links

 
Quick Links for Glaxosmithkline Pharma

Back to Top